Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
1 clinical trials · Condition
◉ Watch Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Phase 1 and 2 Study of PX-866 and Cetuximab (NCT01252628) | Cascadian Therapeutics Inc. | 2010-12-01 |
Track Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.